Wearables

This channel includes news and new technology innovations for wearable cardiac diagnostic systems. These include technologies related to smart phone apps, wearable monitors, consumer-grade wearables and medical grade FDA cleared wearables. A good overview on the future of these technologies can be found in this article.

AliveCor's KardiaMobile six-lead ECG system that works on smartphone platforms. It was cleared in 2019 and includes artificial intelligence algorithms to help identify arrhythmias.

AliveCor's KardiaMobile six-lead ECG system that works on smartphone platforms. It was cleared in 2019 and includes artificial intelligence algorithms to help identify arrhythmias. 

News | Wearables | October 31, 2019

October 31, 2019 — AliveCor, a provider of smartphone based ECG technology and Huami Corp., a provider of biometric...

Fitbit trackers could help detect atrial fibrillation
News | Wearables | October 17, 2019

October 17, 2019 — The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in...

Corvia Medical and physIQ Partner in Global Phase 3 Heart Failure Device Clinical Trial

The REDUCE LAP HF-II study will combine Corvia Medical's InterAtrial Shunt Device (IASD), pictured here, with physIQ's continuous monitoring platform to evaluate the device's efficacy in patients with heart failure. Image courtesy of Corvia Medical.

News | Heart Failure | September 12, 2019

September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a...

InfoBionic’s MoMe Kardia remote ECG monitor is an example of the newer generation devices that are replacing traditional Holter monitors. It has a single button for patients to create an alert when they are experiencing arrhythmia symptoms.

InfoBionic’s MoMe Kardia remote ECG monitor is an example of the newer generation devices that are replacing traditional Holter monitors. It has a single button for patients to create an alert when they are experiencing arrhythmia symptoms.

Feature | ECG Wireless Remote Access | August 30, 2019 | Stuart Long and Colin Movsowitz, M.D.
Until recently, cardiologists trying to diagnose and treat arrhythmias have had to deal with technological limitations...
The Apple Watch is being used to help identify and track Afib in the general population.

The Apple Watch is being used to help identify and track Afib in the general population.  

Blog | Wearables | August 29, 2019
Bardy Diagnostics Selected for HealthTech Arkansas Accelerator Program
News | Wearables | August 15, 2019

August 15, 2019 — Bardy Diagnostics Inc. announced that...

European Society of Cardiology Hosting First Digital Summit
News | Information Technology | July 05, 2019

July 5, 2019 — The rapid evolution of...

Bardy Diagnostics Wins MedTech Breakthrough Award for Best New Diagnostic Technology
News | Wearables | June 14, 2019

June 14, 2019 — Bardy Diagnostics Inc. announced that its Carnation Ambulatory Monitor (CAM) was recognized with the...

More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

News | Atrial Fibrillation | May 13, 2019

May 13, 2019 — A digital screening for...

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki

Technology has made its way into the healthcare sector and brought a drastic transformation. Detection of heart...

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019

The American College of Cardiology (ACC) released a list of the...

Overlay Init